Skip to main content

Braidwell LP

SEC CIK
0001920938
Latest filing
Aug 14, 2026

KRYS holding history

Krystal Biotech, Inc. in every 13F filed by Braidwell LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

KRYS overviewAll 13F holders of KRYSFull Q2 2026 holdings

Shares (Q2 2026)
128,975
Value
$47.9M
% of portfolio
1.8%
Quarters held
15
Since Q4 2022
Holdings of KRYS by Braidwell LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026128,975$47.9M1.8%−53,450−29.3%ReducedHolders
Q1 2026182,425$47.1M1.6%−19,676−9.7%ReducedHolders
Q4 2025202,101$49.8M1.6%−318,300−61.2%ReducedHolders
Q3 2025520,401$91.9M2.7%−207,410−28.5%ReducedHolders
Q2 2025727,811$100.0M3.4%+327,067+81.6%AddedHolders
Q1 2025400,744$72.3M2.5%+200,244+99.9%AddedHolders
Q4 2024200,500$31.4M0.9%+31,809+18.9%AddedHolders
Q3 2024168,691$30.7M0.9%+61,512+57.4%AddedHolders
Q2 2024107,179$19.7M0.6%−69,910−39.5%ReducedHolders
Q1 2024177,089$31.5M1.0%−19,111−9.7%ReducedHolders
Q4 2023196,200$24.3M0.9%+118,703+153.2%AddedHolders
Q3 202377,497$8.99M0.3%−163,902−67.9%ReducedHolders
Q2 2023241,399$28.3M0.9%−106,637−30.6%ReducedHolders
Q1 2023348,036$27.9M0.9%−10,020−2.8%ReducedHolders
Q4 2022358,056$28.4M1.0%–No prior filingHolders